| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 21/04/2006 | 19:02 | PR Newswire (US) | Boston Scientific Completes Combination with Guidant | NYSE:GDT | Guidant Corp |
| 21/04/2006 | 15:12 | PR Newswire (US) | Abbott Completes Acquisition of Guidant Vascular Business | NYSE:GDT | Guidant Corp |
| 20/04/2006 | 15:00 | PR Newswire (US) | Boston Scientific Receives FTC Antitrust Approval for its Combination with Guidant | NYSE:GDT | Guidant Corp |
| 12/04/2006 | 01:05 | PR Newswire (US) | Standard & Poor's Announces Changes to U.S. Indices | NYSE:GDT | Guidant Corp |
| 11/04/2006 | 19:59 | PR Newswire (US) | Boston Scientific Receives European Commission's Antitrust Clearance for Guidant Transaction | NYSE:GDT | Guidant Corp |
| 05/04/2006 | 23:34 | PR Newswire (US) | Boston Scientific Signs Agreement Resolving All Outstanding Antitrust Issues With FTC Staff on Guidant Transaction | NYSE:GDT | Guidant Corp |
| 05/04/2006 | 23:25 | Business Wire | Guidant Announces Preliminary First Quarter 2006 Sales | NYSE:GDT | Guidant Corp |
| 31/03/2006 | 19:03 | PR Newswire (US) | Boston Scientific and Guidant Shareholders Each Approve Combination | NYSE:GDT | Guidant Corp |
| 29/03/2006 | 15:00 | Business Wire | Guidant to Temporarily Suspend XIENCE V Supply; Company Expects European Launch of XIENCE V in Third Quarter 2006 | NYSE:GDT | Guidant Corp |
| 24/03/2006 | 00:10 | PR Newswire (US) | Boston Scientific Makes Antitrust Commitments To European Commission | NYSE:GDT | Guidant Corp |
| 21/03/2006 | 13:30 | Business Wire | Guidant Receives Independent Panel Report and Recommendations; Panel Chaired by Dr. Myerburg, an Internationally Recognized Lea | NYSE:GDT | Guidant Corp |
| 21/03/2006 | 13:25 | PR Newswire (US) | Independent Panel Commissioned by Guidant Issues Report and Recommendations | NYSE:GDT | Guidant Corp |
| 20/03/2006 | 15:30 | PR Newswire (US) | Institutional Shareholder Services Recommends That Shareholders of Boston Scientific and Guidant Approve Combination | NYSE:GDT | Guidant Corp |
| 17/03/2006 | 15:00 | Business Wire | Guidant Announces Enrollment of First Patient in Landmark Carotid Artery Stenting Study; 10,000-Patient Study Aims to Further U | NYSE:GDT | Guidant Corp |
| 16/03/2006 | 20:30 | Business Wire | Guidant to Expand Southern California Facilities; Drug Eluting and Carotid Stents, Emerging Therapies Drive Expansion | NYSE:GDT | Guidant Corp |
| 15/03/2006 | 20:29 | Business Wire | Guidant Completes Enrollment in Randomized U.S. Portion of Drug Eluting Stent Pivotal Trial; Large-Scale Trial Evaluating Safet | NYSE:GDT | Guidant Corp |
| 14/03/2006 | 21:58 | Business Wire | Guidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients Suggest | NYSE:GDT | Guidant Corp |
| 13/03/2006 | 15:00 | Business Wire | Guidant Initiates Voluntary Worldwide Physician Communication Regarding Implantable Cardiac Defibrillators | NYSE:GDT | Guidant Corp |
| 10/03/2006 | 19:00 | Business Wire | R. Frederick McCoy, Jr., Elects Early Retirement from Guidant | NYSE:GDT | Guidant Corp |
| 09/03/2006 | 18:00 | Business Wire | Guidant Launches Innovative Cobalt Chromium Biliary Stent; RX HERCULINK ELITE Biliary Stent System Provides Superb Deliverabili | NYSE:GDT | Guidant Corp |
| 09/03/2006 | 15:02 | Business Wire | Guidant Announces Enrollment of First Patient in Clinical Trial of the World's First Fully Bioabsorbable Drug Eluting Coronary | NYSE:GDT | Guidant Corp |
| 06/03/2006 | 17:14 | PR Newswire (US) | Seven Summits Research Releases Comments on GM, RIMM, CELG, GDT, and LEXR | NYSE:GDT | Guidant Corp |
| 03/03/2006 | 00:11 | PR Newswire (US) | Boston Scientific and Guidant Proposed Merger Registration Statement Declared Effective | NYSE:GDT | Guidant Corp |
| 23/02/2006 | 18:09 | PR Newswire (US) | Boston Scientific Files Notification with European Commission | NYSE:GDT | Guidant Corp |
| 23/02/2006 | 14:31 | Business Wire | Guidant Announces Completion of FDA Inspection of St. Paul Facilities; Company Reports One Inspection Observation and Reiterates | NYSE:GDT | Guidant Corp |
| 07/02/2006 | 14:00 | Business Wire | Theregen Announces Equity Investment from Guidant Corporation to Develop Anginera(TM) Epicardial Patch | NYSE:GDT | Guidant Corp |
| 06/02/2006 | 16:32 | PR Newswire (US) | Boston Scientific Files Hart-Scott-Rodino Pre-Merger Notification | NYSE:GDT | Guidant Corp |
| 30/01/2006 | 20:02 | Business Wire | Guidant Receives European Approval for Drug Eluting Coronary Stent; Company Achieves CE Mark Approval Ahead of Schedule; XIENCE | NYSE:GDT | Guidant Corp |
| 27/01/2006 | 14:30 | Business Wire | Guidant Reports Fourth Quarter Sales of $828 Million; Full Year 2005 Sales of $3.55 Billion; Earnings from Continuing Operations | NYSE:GDT | Guidant Corp |
| 25/01/2006 | 13:02 | PR Newswire (US) | Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion | NYSE:GDT | Guidant Corp |
